Register
Login:
Share:
Email Facebook Twitter

Is the Bull Market over? Andre Minassian says no! Watch here

Is the Bull Market over? Andre Minassian says no!


Scancell Holdings Share Price (SCLP)



Share Price Information for Scancell Holdings (SCLP)


Share Price: 14.25Bid: 14.00Ask: 14.50Change: 0.00 (0.00%)No Movement on Scancell Hldgs
Spread: 0.50Spread as %: 3.57%Open: 14.25High: 14.25Low: 14.25Yesterday’s Close: 14.25

Scancell Holdings Plc Ord 0.1P

Scancell Holdings is listed in the FTSE AIM All-Share
Scancell Holdings is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
14.25

Share Price SpacerBid
14.00

Share Price SpacerAsk
14.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
108,674

Share Price SpacerOpen
14.25

Share Price SpacerHigh
14.25

Share Price SpacerLow
14.25

Share Price SpacerClose
14.25

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 261.56m £37.27m 10,000

52 Week High 21.50 52 Week High Date 7-MAR-2016
52 Week Low 13.00 52 Week Low Date 17-JUN-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
4 5,088 103,586 -12.500 -1.14 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

20-Jan-17
16:04:26
14.383
2,522
Buy* 
14.00
14.50
362.74
Trade Type:
Ordinary

20-Jan-17
13:14:15
14.50
100,000
Buy* 
14.00
14.50
14.50k
Trade Type:
Ordinary

20-Jan-17
10:27:47
14.07
5,088
Sell* 
14.00
14.50
715.88
Trade Type:
Ordinary




View more Scancell Holdings trades >>

Directors Deals for Scancell Holdings (SCLP)
Trade DateActionNotifierPriceCurrencyAmountHolding
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
000
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Richard Goodfellow held the position of Joint CEO at Scancell Holdings at the time of this trade.
 Richard Goodfellow
000
21-Oct-13Sell
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
30GBX100,0000
View more Scancell Holdings directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Sun 23:48inanacoboomorbust14.25No Opinion
In the adjuvant setting, SCIB1 will dominate because of safety ........ i think only patients progressing would a PD1 be added. Wait the trial soon know of the advantage.
Sun 22:57boomorbustInanaco14.25No Opinion
I wonder in the neo-adjuvant setting whether there would be a case for combination of checkpoint inhibitor plus SCIB1 especially for patients with greater tumour load?

Who knows? Nevertheless, it would seem that by the time SCIB1 gets to trial in the adjuvant setting, the landscape will be different and the standard of care treatment for the control arm of the SCIB1 trial probably won't be interferon or Yervoy but more likely one of the PD-1's/L1's.
Sun 22:29inanacoboomorbust14.25No Opinion
Still leaves the market wide open for Scancell in that arena,even in the neo pre-surgery application, but we win hands down because of zero toxicity. It would be interesting to know the result if the surgery was delayed by 6 months prior, if the resultant T cell Build up if given only SCIb1 would be greater with the cancer in place but still checked from growing by the release of the immune response, then surgery to remove the cancer, with further boosters to maintain that response.
Sun 20:15boomorbustAdjuvant therapy14.25No Opinion
Below is link to a very good summary of the current state of play of adjuvant therapies for melanoma. Interesting to note the move towards neo-adjuvant therapy and also the ongoing trials some of which are due to report this year.

http://melanomainternational.org/2016/12/adjuvant-therapy-decisions/#.WIUPzGemljo
Sun 19:47CHELSEA7RE: America First : Impact on Scancell14.25Strong Buy
2cvguy, for sure everybody has an opinion, fortunately on our traditional off topic Sunday a few of us had something to say and it is always good to share how we feel about Scancell, our stratagies in an honest way.

One aspect of this share is the reality of living with cancer, its complications and it is very hard to get over the deep psychological harm being diagnosed and given a short prognosis has on sufferers. I remember The Melanoma Kid with fondness. He didn"t make it as still… Read More
Sun 18:09ratcliffewriterRE: America First : Impact on Scancell14.25Strong Buy
He also made a boo boo by having such a go at the CIA. They'll be organising an open topped drive through Dallas for him next....

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Scancell Holdings (SCLP) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.